NEW YORK (GenomeWeb News) – Bioinformatics firm GenoSplice Technology and Institut Curie's Curie-Cancer today said they are collaborating in the area of cancer genomics.

GenoSplice will have access to several Curie-Cancer technology platforms and be included in Institut Curie research programs. In addition to contributing to the development of new oncology products, the collaboration will result in a better understanding of complex diseases through genome mapping, the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.